Elevated plasminogen activator inhibitor-1 (PAI-1) levels, commonly seen in these patients, inhibit fibrinolysis, leading to microvascular thrombosis and contributing to multi-organ failure. This evidence concerns the gene SERPINE1 and Venous thrombosis.